Sandoz US subsidiaries resolve generic drug antitrust class action litigation with direct purchaser class plaintiffs 29-02-2024, 13:00

David Gagne Named President and Chief Executive Officer of 15-02-2023, 19:08

Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition 9-11-2024, 02:51